Related references
Note: Only part of the references are listed.Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma
Junfeng Wang et al.
JOURNAL OF HEPATOLOGY (2021)
LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy
Naveen Sharma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation
Andras Lanczky et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2021)
SCISSOR™: a single-cell inferred site-specific omics resource for tumor microenvironment association study
Xiang Cui et al.
NAR CANCER (2021)
Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
Balazs Gyorffy
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Imran G. House et al.
CLINICAL CANCER RESEARCH (2020)
MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2
Meng Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
miR-155 Overexpression in OT-1 CD8+ T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen
Gwennaelle C. Monnot et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Overexpression of microRNA-155 enhances the efficacy of dendritic cell vaccine against breast cancer
Johnie Hodge et al.
ONCOIMMUNOLOGY (2020)
Exosomal miRNAs in tumor microenvironment
Shiming Tan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance
Patrick Santos et al.
CELLS (2020)
Determining cell type abundance and expression from bulk tissues with digital cytometry
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2019)
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
Denarda Dangaj et al.
CANCER CELL (2019)
CXCR3-CXCL9: It's All in the Tumor
Etienne Humblin et al.
IMMUNITY (2019)
Circulating MicroRNAs in Cancer: Potential and Challenge
Mengying Cui et al.
FRONTIERS IN GENETICS (2019)
The molecular basis of JAK/STAT inhibition by SOCS1
Nicholas P. D. Liau et al.
NATURE COMMUNICATIONS (2018)
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
Katrien Van Roosbroeck et al.
CLINICAL CANCER RESEARCH (2017)
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
Rimi Hamam et al.
CELL DEATH & DISEASE (2017)
Efficient and simple approach to in vitro culture of primary epithelial cancer cells
Karolina Janik et al.
BIOSCIENCE REPORTS (2016)
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
Andras Lanczky et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
CXCL9: evidence and contradictions for its role in tumor progression
Qiang Ding et al.
CANCER MEDICINE (2016)
microRNA-155 deficiency impairs dendritic cell function in breast cancer
Junfeng Wang et al.
OncoImmunology (2016)
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
Rosa Barreira da Silva et al.
NATURE IMMUNOLOGY (2015)
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
Antoni Ribas
CANCER DISCOVERY (2015)
MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges
Huiyin Lan et al.
BIOMED RESEARCH INTERNATIONAL (2015)
MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth
Junfeng Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
microRNA-155 promotes the proliferation of prostate cancer cells by targeting annexin 7
Zhi-Kang Cai et al.
MOLECULAR MEDICINE REPORTS (2015)
Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer
W. Kong et al.
ONCOGENE (2014)
Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation
Pierluigi Gasparini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice
Erika Zonari et al.
BLOOD (2013)
MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
Jan C. Dudda et al.
IMMUNITY (2013)
The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository
Kenneth Clark et al.
JOURNAL OF DIGITAL IMAGING (2013)
miR-155-Deficient Bone Marrow Promotes Tumor Metastasis
Fang Yu et al.
MOLECULAR CANCER RESEARCH (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
OncomiR Addiction Is Generated by a miR-155 Feedback Loop in Theileria-Transformed Leukocytes
Justine Marsolier et al.
PLOS PATHOGENS (2013)
Adrenaline promotes cell proliferation and increases chemoresistance in colon cancer HT29 cells through induction of MiR-155
Jun Pu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Hepatitis C Virus-Induced Up-Regulation of MicroRNA-155 Promotes Hepatocarcinogenesis by Activating Wnt Signaling
Yiliang Zhang et al.
HEPATOLOGY (2012)
Clinical significance of MicoRNA-155 expression in human breast cancer
Jian Chen et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1
Joo Hyun Kim et al.
LEUKEMIA & LYMPHOMA (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells
Imran A. Babar et al.
CANCER BIOLOGY & THERAPY (2011)
miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT
X. Xiang et al.
ONCOGENE (2011)
MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development
Ryan M. O'Connell et al.
IMMUNITY (2010)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
MicroRNA-155 Regulates Inflammatory Cytokine Production in Tumor-associated Macrophages via Targeting C/EBPβ
Min He et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Onco-miR-155 targets SHIP1 to promote TNFα-dependent growth of B cell lymphomas
Irene M. Pedersen et al.
EMBO MOLECULAR MEDICINE (2009)
MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells
Elena Vigorito et al.
IMMUNITY (2007)
Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment
Diego O. Croci et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development
Meritxell Gironella et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Role of STAT3 in type I interferon responses - Negative regulation of STAT1-dependent inflammatory gene activation
Hao H. Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
